Dicot addresses great need for new treatments of erectile dysfunction
Press release: Uppsala, March 17, 2022. The demand for potency drugs has increased by 41% in the last three years, according to statistics from IQVIA. Despite this, drugs available today do not manage to treat everyone in need. For example, up to 30-40% do not respond properly. The Swedish pharmaceutical company Dicot is developing a new type of potency drug to address this need.Despite the fact that the demand for potency drugs is rising, there are deficiencies among those present on the market today and who were introduced twenty years ago. Between 30 and 40 percent of patients do not